Miller, A A <br/><br/>
Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  May 1997 
 - 719-25 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacokinetics<br/>Bone Marrow--pathology<br/>Carcinoma, Small Cell--drug therapy<br/>Cisplatin--administration & dosage<br/>Disease-Free Survival<br/>Etoposide--administration & dosage<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Regression Analysis<br/>Time Factors